Back to Evidence
Paper-scoped peptide mentionSequence reported

Ang II

PMC12296148::PEP000003

Source publication

Aminopeptidase A Effect on Angiotensin Peptides and Their Blood Pressure Action

International Journal of Molecular Sciences · 2025

Sequence status
reported
Standardization
Sequence ready
Source location
text
Activity records
4

Sequence evidence

Reported molecular identity

DRVYIHPF

Ang II (1-8) is described as an octapeptide with N-terminal aspartate; sequence inferred from standard RAS nomenclature used in the paper.

Resolved peptide links

Experimental observations

Records linked to this mention

Metabolic/CardiovascularOtherPositive observation
Record detail

In the in vitro assay, the murine rAPA (mrAPA) showed a substantial cleavage of aspartate from Ang II (22,437 ± 3358 RFU, N = 12).

Measure
percent_inhibition
Value
22,437 ± 3358 RFU
Target
Mus musculus
Assay
Not reported by source
Source publication
Metabolic/CardiovascularOtherPositive observation
Record detail

Recombinant APA accelerated the return of the SBP to pre-infusion levels elicited by ... Ang II (Figure 4 in the middle panel) (p = 0.0082).

Measure
survival_rate
Value
p = 0.0082
Target
Mus musculus
Assay
Not reported by source
Source publication
Metabolic/CardiovascularOtherPositive observation
Record detail

The hypertensive effect of Ang II was quickly abolished by the administration of rACE2 (p = 0.02) (Figure 7). Over ten minutes p = 0.0248.

Measure
survival_rate
Value
p = 0.0248
Target
Mus musculus
Assay
Not reported by source
Source publication

Local peptide labels such as P1, PEP1, or peptide 1 are grouped only within this paper and are not assumed to represent the same molecule across publications.